| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor
|
Abbas, Richat
|
|
2012
|
70 |
1 |
p. 191-199
|
article
|
| 2 |
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer
|
Karachaliou, N.
|
|
2012
|
70 |
1 |
p. 169-176
|
article
|
| 3 |
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
|
Vlahovic, Gordana
|
|
2012
|
70 |
1 |
p. 95-102
|
article
|
| 4 |
A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors
|
Leong, S.
|
|
2012
|
70 |
1 |
p. 65-74
|
article
|
| 5 |
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
|
Fury, Matthew G.
|
|
2012
|
70 |
1 |
p. 121-128
|
article
|
| 6 |
Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies
|
Shimada, Muneaki
|
|
2012
|
70 |
1 |
p. 33-38
|
article
|
| 7 |
Comparison of a homologous series of benzonaphthyridine anti-cancer agents in mice: divergence between tumour and plasma pharmacokinetics
|
Lukka, Pradeep B.
|
|
2012
|
70 |
1 |
p. 151-160
|
article
|
| 8 |
Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers
|
Pithavala, Yazdi K.
|
|
2012
|
70 |
1 |
p. 103-112
|
article
|
| 9 |
Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine
|
Kissow, Hannelouise
|
|
2012
|
70 |
1 |
p. 39-48
|
article
|
| 10 |
Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro
|
Kamen, B. A.
|
|
2012
|
70 |
1 |
p. 113-120
|
article
|
| 11 |
Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy
|
Damodaran, Solai Elango
|
|
2012
|
70 |
1 |
p. 75-81
|
article
|
| 12 |
Intra-CSF administration of chemotherapy medications
|
Gabay, Michael P.
|
|
2012
|
70 |
1 |
p. 1-15
|
article
|
| 13 |
Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children’s oncology group
|
Edwards, Alena Y. Z.
|
|
2012
|
70 |
1 |
p. 83-94
|
article
|
| 14 |
Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study
|
Kentepozidis, N.
|
|
2012
|
70 |
1 |
p. 161-168
|
article
|
| 15 |
Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53
|
Chiorean, E. Gabriela
|
|
2012
|
70 |
1 |
p. 25-32
|
article
|
| 16 |
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes
|
Lustberg, Maryam B.
|
|
2012
|
70 |
1 |
p. 49-56
|
article
|
| 17 |
Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer
|
Farid, Mohamad
|
|
2012
|
70 |
1 |
p. 141-150
|
article
|
| 18 |
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors
|
Aregbe, Abdulateef O.
|
|
2012
|
70 |
1 |
p. 201-205
|
article
|
| 19 |
Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers
|
Choy, Gavin
|
|
2012
|
70 |
1 |
p. 183-190
|
article
|
| 20 |
Single- and multiple-dose pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in Chinese men with advanced solid tumors
|
Li, Jin
|
|
2012
|
70 |
1 |
p. 57-63
|
article
|
| 21 |
The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas
|
Grossman, Rachel
|
|
2012
|
70 |
1 |
p. 129-139
|
article
|
| 22 |
The minimal impact of food on the pharmacokinetics of ridaforolimus
|
Stroh, Mark
|
|
2012
|
70 |
1 |
p. 177-182
|
article
|
| 23 |
The “survivin suppressants” NSC 80467 and YM155 induce a DNA damage response
|
Glaros, Trevor G.
|
|
2012
|
70 |
1 |
p. 207-212
|
article
|
| 24 |
Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats
|
Hajjaji, Nawale
|
|
2012
|
70 |
1 |
p. 17-23
|
article
|
Journal description